Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial

The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.

Authors

Institutions

Publication Details

Journal
Clinical Diabetes
Published
2025-02-24
DOI
https://doi.org/10.2337/cd24-0104
Citations
2
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
2.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial

Kelsey B. Huss, Evelyn Greaux, Hui Zheng, Amy Sabean et al.
2 citations
Clinical Diabetes
Diabetes Management and Research
2.59
article

Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial

Kelsey B. Huss, Evelyn Greaux, Hui Zheng, Amy Sabean, COURTNEY A. BALLIRO, Sean M. Oser, Elizabeth Westfeldt, Britney Prince, Tamara K. Oser, Jessica Parascando, Steven J. Russell, Rachel Bartholomew, Mallory Hillard, Nillani Anandakugan, Sarah Gaston, Melissa S. Putman, Edward R. Damiano, Mollie Y. O’Connor, A Ashley
article en
2 citations

Abstract

The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.

Clinical DiabetesVol. 43(3)
Boston University (US), Concord Consortium (US), Massachusetts General Hospital (US), University of Colorado Anschutz Medical Campus (US)
Leona M. and Harry B. Helmsley Charitable Trust
Openalex Percentile: Top 12%
Diabetes Management and Research
2.59
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.